Table 1.
Factor | Study group (n = 62) |
---|---|
Gender | |
Male | 51 (82.2%) |
Female | 11 (17.8%) |
Age, median (range) | 63 (42–87) |
≥ 63 | 32 (48.4% |
< 63 | 30 (51.6%) |
Histopathological diagnosis | |
Squamous-cell carcinoma | 57 (91.9%) |
Other | 5 (8.1%) |
Tumor location | |
Upper throat | 17 (27.4%) |
Lower throat | 45 (72.6%) |
Larynx | 34 (54.8%) |
Others | 28 (45.2%) |
T stage | |
T1 | 2 (3.2%) |
T2 | 9 (14.5%) |
T3 | 15 (24.2%) |
T4 | 36 (58.1%) |
N stage | |
Nx | 2 (3.2%) |
N0 | 18 (29%) |
N1 | 6 (9.7%) |
N2 | 32(51.6%) |
N3 | 4 (6.5%) |
M stage | |
Mx | 3(75%) |
M1 | 1 (25%) |
Disease stage | |
I | 2 (3.2%) |
III | 12 (19.4%) |
IVA | 40 (64.5%) |
IVB | 3 (4.8%) |
IVC | 5 (8.1%) |
Performance status (PS) | |
≤ 1 | 55 (88.7%) |
> 1 | 7 (11.3%) |
Type of treatment | |
Surgery + RTH | 28 (45.2%) |
Surgery + chemoradiation | 17 (27.4%) |
RTH alone | 7 (11.3%) |
Induction CHTH + RTH | 3 (4.8%) |
Concurrent chemoradiation | 7 (11.3%) |
Alcohol consumption | |
Yes | 28 (45.2%) |
No | 34 (54.8%) |
Smoking status | |
Smoker | 52 (83.9%) |
Non-smoker | 10 (16.1%) |
Current smoker | 45 (86.5%) |
Former smoker | 7 (13.5%) |
Nutritional status | |
Parenteral nutrition | |
Yes | 13 (21%) |
No | 49 (79%) |
Weight (kg) | |
Mean ± SD | 65.63 ± 11.93 |
BMI | |
Mean ± SD | 23.13 ± 4.44 |
> 18.5 | 52 (83.9%) |
< 18.5 | 10 (16.1%) |
SGA | |
A | 9 (14.5%) |
B | 29 (46.8%) |
C | 24 (38.7%) |
NRS | |
2 | 42 (67.8%) |
3 | 18 (29%) |
4 | 2 (3.2) |
Total protein (g/L) | |
Median ± SD | 6.72 ± 0.52 |
Albumin (g/L) | |
Median ± SD | 3.33 ± 0.24 |
Prealbumin(g/dL) | |
Median ± SD | 0.20 ± 0.08 |
Transferrin(g/L) | |
Median ± SD | 2.50 ± 0.60 |